Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Abdelbasset Atia, Ahmed I. Gomma, Ismail Fliss, Eric Beyssac, Ghislain Garrait & Muriel Subirade. (2017) Molecular and biopharmaceutical investigation of alginate–inulin synbiotic coencapsulation of probiotic to target the colon. Journal of Microencapsulation 34:2, pages 171-184.
Read now
Read now
Malabi M Venkatesan & Lillian L Van de Verg. (2015) Combination vaccines against diarrheal diseases. Human Vaccines & Immunotherapeutics 11:6, pages 1434-1448.
Read now
Read now
Sachin N Desai, Alejandro Cravioto, Dipika Sur & Suman Kanungo. (2014) Maximizing protection from use of oral cholera vaccines in developing country settings. Human Vaccines & Immunotherapeutics 10:6, pages 1457-1465.
Read now
Read now
Anne L Bishop & Andrew Camilli. (2011) Vibrio cholerae: lessons for mucosal vaccine design. Expert Review of Vaccines 10:1, pages 79-94.
Read now
Read now
Ashraful I. Khan, Fahima Chowdhury, Jason B. Harris, Regina C. Larocque, Abu S. G. Faruque, Edward T. Ryan, Stephen B. Calderwood & Firdausi Qadri. (2010) Comparison of clinical features and immunological parameters of patients with dehydrating diarrhoea infected with Inaba or Ogawa serotypes of Vibrio cholerae O1. Scandinavian Journal of Infectious Diseases 42:1, pages 48-56.
Read now
Read now
Mohiul Islam Chowdhury, Alaullah Sheikh & Firdausi Qadri. (2009) Development of Peru-15 (CholeraGarde®), a live-attenuated oral cholera vaccine: 1991–2009. Expert Review of Vaccines 8:12, pages 1643-1652.
Read now
Read now
Gideon Kersten & Hoang Hirschberg. (2007) Needle-free vaccine delivery. Expert Opinion on Drug Delivery 4:5, pages 459-474.
Read now
Read now
Lisa Olsson & Per-Arne Parment. (2006) Present and future cholera vaccines. Expert Review of Vaccines 5:6, pages 751-752.
Read now
Read now
Articles from other publishers (41)
Rui Zhang, Xingxiang Duan, Ye Liu, Jia Xu, Abdullkhaleg Ali Ghaleb Al-bashari, Peng Ye, Qingsong Ye & Yan He. (2023) The Application of Mesenchymal Stem Cells in Future Vaccine Synthesis. Vaccines 11:11, pages 1631.
Crossref
Crossref
Brandon Sit, Bolutife Fakoya & Matthew K. Waldor. (2022) Emerging Concepts in Cholera Vaccine Design. Annual Review of Microbiology 76:1, pages 681-702.
Crossref
Crossref
Yilin Zhang, Ziyu Zhang, Jinxia Zhang, Yucong Huang, Jichang Jian & Shuanghu Cai. (2022) A live attenuated strain of HY9901ΔdctP provides protection against Vibrio alginolyticus to the pearl gentian grouper (♀Epinephelus fuscoguttatus × ♂Epinephelus lanceolatus). Frontiers in Marine Science 9.
Crossref
Crossref
Bolutife Fakoya, Karthik Hullahalli, Daniel H. F. Rubin, Deborah R. Leitner, Roma Chilengi, David A. Sack & Matthew K. Waldor. (2022) Nontoxigenic Vibrio cholerae Challenge Strains for Evaluating Vaccine Efficacy and Inferring Mechanisms of Protection. mBio 13:2.
Crossref
Crossref
Negar Souod, Mohammad Kargar, Mohammad Hossein Hoseini & Mojtaba Jafarinia. (2021) Fusion-expressed CtxB-TcpA-C-CPE improves both systemic and mucosal humoral and T-cell responses against cholera in mice. Microbial Pathogenesis 157, pages 104978.
Crossref
Crossref
Deepak Balasubramanian, Sebastian Murcia, C. Brandon Ogbunugafor, Ronnie Gavilan & Salvador Almagro-Moreno. (2021) Cholera dynamics: lessons from an epidemic. Journal of Medical Microbiology 70:2.
Crossref
Crossref
Gyusaang Youn, Jakob Cervin, Xiaoxi Yu, Surita R. Bhatia, Ulf Yrlid & Nicole S. Sampson. (2020) Targeting Multiple Binding Sites on Cholera Toxin B with Glycomimetic Polymers Promotes the Formation of Protein–Polymer Aggregates. Biomacromolecules 21:12, pages 4878-4887.
Crossref
Crossref
Tew Hui Xian, Kurunathan Sinniah, Chan Yean Yean, Venkateskumar Krishnamoorthy, Mohd Baidi Bahari, Manickam Ravichandran & Guruswamy Prabhakaran. (2020) Immunogenicity and protective efficacy of a live, oral cholera vaccine formulation stored outside-the-cold-chain for 140 days. BMC Immunology 21:1.
Crossref
Crossref
Omkar ChaudharyLingyun WangDeepanwita BoseVivek NarayanMing Te YehAngela CarvilleJohn D. ClementsRaul AndinoPamela A. KozlowskiAnna Aldovini. (2020) Comparative Evaluation of Prophylactic SIV Vaccination Modalities Administered to the Oral Cavity. AIDS Research and Human Retroviruses 36:12, pages 984-997.
Crossref
Crossref
Dain Kim, Jisu Hong, Yoonjoo Choi, Jemin Han, Sangkyu Kim, Gyunghee Jo, Jun-Yeol Yoon, Heesu Chae, Hyeseon Yoon, Chankyu Lee & Hyo Jeong Hong. (2020)
Generation and Characterization of Monoclonal Antibodies to the Ogawa Lipopolysaccharide of
Vibrio cholerae
O1 from Phage-Displayed Human Synthetic Fab Library
. Journal of Microbiology and Biotechnology 30:11, pages 1760-1768.
Crossref
Crossref
Hanif Shaikh, Julia Lynch, Jerome Kim & Jean-Louis Excler. (2020) Current and future cholera vaccines. Vaccine 38, pages A118-A126.
Crossref
Crossref
Kathrin Moor & Emma Slack. (2015) What Makes A Bacterial Oral Vaccine a Strong Inducer of High-Affinity IgA Responses?. Antibodies 4:4, pages 295-313.
Crossref
Crossref
Matthew K. Waldor & Edward T. Ryan. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
2471
2479.e2
.
Ana A. Weil & Jason B. Harris. 2015. Molecular Medical Microbiology. Molecular Medical Microbiology
1079
1098
.
Anne L. Bishop, Bharathi Patimalla & Andrew Camilli. (2014) Vibrio cholerae-Induced Inflammation in the Neonatal Mouse Cholera Model. Infection and Immunity 82:6, pages 2434-2447.
Crossref
Crossref
Rudra Chhajer & Nahid Ali. (2014) Genetically Modified Organisms and Visceral Leishmaniasis. Frontiers in Immunology 5.
Crossref
Crossref
Andrea Seper, Ava Hosseinzadeh, Gregor Gorkiewicz, Sabine Lichtenegger, Sandro Roier, Deborah R. Leitner, Marc R?hm, Andreas Grutsch, Joachim Reidl, Constantin F. Urban & Stefan Schild. (2013) Vibrio cholerae Evades Neutrophil Extracellular Traps by the Activity of Two Extracellular Nucleases. PLoS Pathogens 9:9, pages e1003614.
Crossref
Crossref
M. Pastor, J.L. Pedraz & A. Esquisabel. (2013) The state-of-the-art of approved and under-development cholera vaccines. Vaccine 31:38, pages 4069-4078.
Crossref
Crossref
Deborah R. Leitner, Sandra Feichter, Kristina Schild-Prüfert, Gerald N. Rechberger, Joachim Reidl & Stefan Schild. (2013) Lipopolysaccharide Modifications of a Cholera Vaccine Candidate Based on Outer Membrane Vesicles Reduce Endotoxicity and Reveal the Major Protective Antigen. Infection and Immunity 81:7, pages 2379-2393.
Crossref
Crossref
S-S Kang, J S Yang, K W Kim, C-H Yun, J Holmgren, C Czerkinsky & S H Han. (2013) Anti-bacterial and anti-toxic immunity induced by a killed whole-cell-cholera toxin B subunit cholera vaccine is essential for protection against lethal bacterial infection in mouse pulmonary cholera model. Mucosal Immunology 6:4, pages 826-837.
Crossref
Crossref
Aimee L. Richard & Victor J. DiRita. 2013. The Prokaryotes. The Prokaryotes
125
131
.
Talena Ledón, Beatriz Ferrán, Celso Pérez, Edith Suzarte, Joivier Vichi, Karen Marrero, Reinaldo Oliva & Rafael Fando. (2012) TLP01, an mshA mutant of Vibrio cholerae O139 as vaccine candidate against cholera. Microbes and Infection 14:11, pages 968-978.
Crossref
Crossref
Jason B Harris, Regina C LaRocque, Firdausi Qadri, Edward T Ryan & Stephen B Calderwood. (2012) Cholera. The Lancet 379:9835, pages 2466-2476.
Crossref
Crossref
A. A. Tarique, A. Kalsy, M. Arifuzzaman, S. M. Rollins, R. C. Charles, D. T. Leung, J. B. Harris, R. C. LaRocque, A. Sheikh, M. S. Bhuiyan, R. Saksena, J. D. Clements, S. B. Calderwood, F. Qadri, P. Kováč & E. T. Ryan. (2012) Transcutaneous Immunization with a Vibrio cholerae O1 Ogawa Synthetic Hexasaccharide Conjugate following Oral Whole-Cell Cholera Vaccination Boosts Vibriocidal Responses and Induces Protective Immunity in Mice. Clinical and Vaccine Immunology 19:4, pages 594-602.
Crossref
Crossref
Madhubanti Sarkar, Swati Bhowmick, Antonella Casola & Keya Chaudhuri. (2012) Interleukin-8 gene regulation in epithelial cells by Vibrio?cholerae: role of multiple promoter elements, adherence and motility of bacteria and host MAPKs. FEBS Journal 279:8, pages 1464-1473.
Crossref
Crossref
Sachin N. Desai & John D. Clemens. (2012) An overview of cholera vaccines and their public health implications. Current Opinion in Pediatrics 24:1, pages 85-91.
Crossref
Crossref
M. Ali, M. Emch, J. K. Park, M. Yunus & J. Clemens. (2011) Natural Cholera Infection-Derived Immunity in an Endemic Setting. Journal of Infectious Diseases 204:6, pages 912-918.
Crossref
Crossref
Alison Kuchta, Taibur Rahman, Erica L. Sennott, Taufiqur R. Bhuyian, Taher Uddin, Rasheduzzaman Rashu, Fahima Chowdhury, Ashraf I. Kahn, Mohammad Arifuzzaman, Ana A. Weil, Michael Podolsky, Regina C. LaRocque, Edward T. Ryan, Stephen B. Calderwood, Firdausi Qadri & Jason B. Harris. (2011)
Vibrio cholerae O1 Infection Induces Proinflammatory CD4
+
T-Cell Responses in Blood and Intestinal Mucosa of Infected Humans
. Clinical and Vaccine Immunology 18:8, pages 1371-1377.
Crossref
Crossref
Mohammad Murshid Alam, M. Asrafuzzaman Riyadh, Kaniz Fatema, Mohammad Arif Rahman, Nayeema Akhtar, Tanvir Ahmed, Mohiul Islam Chowdhury, Fahima Chowdhury, Stephen B. Calderwood, Jason B. Harris, Edward T. Ryan & Firdausi Qadri. (2011) Antigen-Specific Memory B-Cell Responses in Bangladeshi Adults after One- or Two-Dose Oral Killed Cholera Vaccination and Comparison with Responses in Patients with Naturally Acquired Cholera. Clinical and Vaccine Immunology 18:5, pages 844-850.
Crossref
Crossref
Chen-Shan Chin, Jon Sorenson, Jason B. Harris, William P. Robins, Richelle C. Charles, Roger R. Jean-Charles, James Bullard, Dale R. Webster, Andrew Kasarskis, Paul Peluso, Ellen E. Paxinos, Yoshiharu Yamaichi, Stephen B. Calderwood, John J. Mekalanos, Eric E. Schadt & Matthew K. Waldor. (2011) The Origin of the Haitian Cholera Outbreak Strain. New England Journal of Medicine 364:1, pages 33-42.
Crossref
Crossref
Gordon Dougan, David Goulding & Lindsay J. Hall. 2011. Replicating Vaccines. Replicating Vaccines
3
14
.
Anne L. Bishop, Stefan Schild, Bharathi Patimalla, Brian Klein & Andrew Camilli. (2010)
Mucosal Immunization with
Vibrio cholerae
Outer Membrane Vesicles Provides Maternal Protection Mediated by Antilipopolysaccharide Antibodies That Inhibit Bacterial Motility
. Infection and Immunity 78:10, pages 4402-4420.
Crossref
Crossref
Haopeng Rui, Jennifer M. RitchieRoderick T. BronsonJohn J. MekalanosYuanxing Zhang & Matthew K. Waldor. (2010)
Reactogenicity of live-attenuated
Vibrio cholerae
vaccines is dependent on flagellins
. Proceedings of the National Academy of Sciences 107:9, pages 4359-4364.
Crossref
Crossref
Madushini N. Dharmasena, Shelly J. Krebs & Ronald K. Taylor. (2009) Characterization of a novel protective monoclonal antibody that recognizes an epitope common to Vibrio cholerae Ogawa and Inaba serotypes. Microbiology 155:7, pages 2353-2364.
Crossref
Crossref
Guifang Xu, Shixia Wang, Ling Zhuang, Anthony Hackett, Ling Gu, Lu Zhang, Chunhua Zhang, Hua Wang, Zuhu Huang & Shan Lu. (2009) Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera. Vaccine 27:29, pages 3821-3830.
Crossref
Crossref
Cyrille Grandjean, Alain Boutonnier, Bruno Dassy, Jean-Michel Fournier & Laurence A. Mulard. (2008) Investigation towards bivalent chemically defined glycoconjugate immunogens prepared from acid-detoxified lipopolysaccharide of Vibrio cholerae O1, serotype Inaba. Glycoconjugate Journal 26:1, pages 41-55.
Crossref
Crossref
Regina C. LaRocque, Bryan Krastins, Jason B. Harris, Lauren M. Lebrun, Kenneth C. Parker, Michael Chase, Edward T. Ryan, Firdausi Qadri, David Sarracino & Stephen B. Calderwood. (2008)
Proteomic Analysis of
Vibrio cholerae
in Human Stool
. Infection and Immunity 76:9, pages 4145-4151.
Crossref
Crossref
David R. Tribble, Shahida Baqar & Stuart A. Thompson. 2008. Campylobacter. Campylobacter
429
444
.
Andreas Rolfs, Wagner R. Montor, Sang Sun Yoon, Yanhui Hu, Bhupinder Bhullar, Fontina Kelley, Seamus McCarron, Daniel A. Jepson, Binghua Shen, Elena Taycher, Stephanie E. Mohr, Dongmei Zuo, Janice Williamson, John Mekalanos & Joshua LaBaer. (2008)
Production and sequence validation of a complete full length ORF collection for the pathogenic bacterium
Vibrio cholerae
. Proceedings of the National Academy of Sciences 105:11, pages 4364-4369.
Crossref
Crossref
Madushini N. Dharmasena, David A. Jewell & Ronald K. Taylor. (2007) Development of Peptide Mimics of a Protective Epitope of Vibrio cholerae Ogawa O-antigen and Investigation of the Structural Basis of Peptide Mimicry. Journal of Biological Chemistry 282:46, pages 33805-33816.
Crossref
Crossref
Anupam Hazra, Anisia J. Silva & Jorge A. Benitez. (2007) Expression of foreign proteins in a Vibrio cholerae vaccine strain using the stationary phase hemagglutinin/protease promoter. Biotechnology Letters 29:7, pages 1093-1097.
Crossref
Crossref